Zobrazeno 1 - 10
of 63
pro vyhledávání: '"Koji Waki"'
Autor:
Masahiro Hatooka, Tomokazu Kawaoka, Hiroshi Aikata, Yuki Inagaki, Kei Morio, Takashi Nakahara, Eisuke Murakami, Masataka Tsuge, Akira Hiramatsu, Michio Imamura, Yoshiiku Kawakami, Kazuo Awai, Keiichi Masaki, Koji Waki, Hirotaka Kohno, Hiroshi Kohno, Takashi Moriya, Yuko Nagaoki, Toru Tamura, Hajime Amano, Yoshio Katamura, Kazuaki Chayama
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-10 (2018)
Abstract Background In patients with advanced hepatocellular carcinoma (HCC), evidence is unclear as to whether hepatic arterial infusion chemotherapy (HAIC) or sorafenib is superior. We performed a prospective, open-label, non-comparative phase II s
Externí odkaz:
https://doaj.org/article/b7ffc53bb2d54631a09725a7151575b4
Autor:
Hiroyuki Ito, Keiko Arataki, Hidenori Ochi, Takashi Moriya, Masataka Tsuge, Yuki Nakamura, Keiji Tsuji, Yoshio Katamura, Toshio Nakamura, Eisuke Murakami, Yoshiiku Kawakami, Kei Morio, C. Nelson Hayes, Koji Waki, Kazuaki Chayama, Tomokazu Kawaoka, Daiki Miki, Michio Imamura, Akira Hiramatsu, Masahiro Hatooka, Hiroshi Aikata, Takashi Nakahara, Hiroshi Kohno, Reona Morio, Toru Tamura, Hatsue Fujino
Publikováno v:
Journal of Medical Virology. 90:1834-1840
Background Sustained virological response (SVR) rates for the treatment of chronic hepatitis C virus (HCV)-infected patients have drastically improved with the use of direct-acting antiviral (DAA) therapies; however, a small minority of patients stil
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::937475b5adcf27a582196d5d0b7cd882
https://doi.org/10.1002/jmv.25267
https://doi.org/10.1002/jmv.25267
Autor:
Yoshiiku Kawakami, Hiroyuki Ito, Yuko Nagaoki, Kazuaki Chayama, Keiji Tsuji, Hidenori Ochi, Clair Nelson Hayes, Hajime Amano, Toru Tamura, Akira Hiramatsu, Tomokazu Kawaoka, Masataka Tsuge, Michio Imamura, Hiroshi Aikata, Kei Morio, Grace Naswa Makokha, Takashi Nakahara, Koji Waki, Hiroshi Kohno, Keiko Arataki, Takashi Moriya, Toshio Nakamura
Publikováno v:
Journal of Gastroenterology. 52:746-753
Polymorphisms in the inosine triphosphatase (ITPA) gene is associated with anemia induced by peg-interferon (PEG-IFN) plus ribavirin (RBV) treatment for patients with chronic hepatitis C virus (HCV) infection. However, the effect of ITPA polymorphism
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::07919386eafc300c3f4fb95c3928e5d0
https://doi.org/10.1007/s00535-016-1279-9
https://doi.org/10.1007/s00535-016-1279-9
Autor:
Akira Nakashima, Toshihiko Kohashi, Naoki Hirabayashi, Eisuke Murakami, Hidenori Mukaida, Ichiro Omori, Koji Waki, Hiroaki Yamane
Publikováno v:
Case Reports in Clinical Medicine. :541-547
Background: Radiofrequency ablation (RFA) is an effective treatment for hepatocellular carcinoma (HCC). However, rare but serious complications may occur after RFA. We describe a case of diaphragmatic hernia associated with RFA. Case Presentation: A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::89f47232397e19e3023f05a29a9fe7bf
https://doi.org/10.4236/crcm.2016.512068
https://doi.org/10.4236/crcm.2016.512068
Autor:
Eisuke Murakami, Yuki Inagaki, Hirotaka Kohno, Yuko Nagaoki, Masahiro Hatooka, Toru Tamura, Koji Waki, Takashi Nakahara, Keiichi Masaki, Yoshio Katamura, Michio Imamura, Akira Hiramatsu, Masataka Tsuge, Hiroshi Aikata, Hajime Amano, Kazuaki Chayama, Tomokazu Kawaoka, Kazuo Awai, Yoshiiku Kawakami, Hiroshi Kohno, Kei Morio, Takashi Moriya
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-10 (2018)
BMC Cancer
BMC Cancer
Background In patients with advanced hepatocellular carcinoma (HCC), evidence is unclear as to whether hepatic arterial infusion chemotherapy (HAIC) or sorafenib is superior. We performed a prospective, open-label, non-comparative phase II study to a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b3f552e67e2628443b8cbab312706a1c
https://doi.org/10.1186/s12885-018-4519-y
https://doi.org/10.1186/s12885-018-4519-y
Autor:
Hiroshi Kohno, Kei Morio, Akira Hiramatsu, Yoshiiku Kawakami, Keiji Tsuji, Hiroshi Aikata, Hideyuki Hyogo, Masahiro Hatooka, Hirotaka Kohno, Daisuke Miyaki, Koji Waki, Reona Morio, Tomoki Kobayashi, Shoichi Takahashi, Noriaki Naeshiro, Kazuaki Chayama, Tomokazu Kawaoka, Michio Imamura, Takayuki Fukuhara, Takashi Moriya
Publikováno v:
Journal of Digestive Diseases. 16:505-512
Objectives Sorafenib is the standard treatment for advanced hepatocellular carcinoma (HCC) with distant metastasis, unresectable HCC, and those refractory to transcatheter arterial chemoembolization (TACE) or with macroscopic vascular invasion (MVI).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1e5a28c32c4e405322e6694a21767ea4
https://doi.org/10.1111/1751-2980.12267
https://doi.org/10.1111/1751-2980.12267
Autor:
Masahiro, Hatooka, Tomokazu, Kawaoka, Hiroshi, Aikata, Kei, Morio, Tomoki, Kobayashi, Akira, Hiramatsu, Michio, Imamura, Yoshiiku, Kawakami, Eisuke, Murakami, Koji, Waki, Yoji, Honda, Nami, Mori, Shintaro, Takaki, Keiji, Tsuji, Hirotaka, Kohno, Hiroshi, Kohno, Takashi, Moriya, Michihiro, Nonaka, Hideyuki, Hyogo, Yasuyuki, Aisaka, Kazuaki, Chayama
Publikováno v:
Anticancer research. 36(7)
To compare the outcome of 5-fluorouracil (FU)-based hepatic arterial infusion chemotherapy (HAIC) with sorafenib monotherapy in patients with hepatocellular carcinoma (HCC) refractory to transcatheter arterial chemoembolization (TACE).In this retrosp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::5d63c5da845e1e38a69893dd223fbcdc
https://pubmed.ncbi.nlm.nih.gov/27354618
https://pubmed.ncbi.nlm.nih.gov/27354618
Autor:
Kazuaki Chayama, Yuko Nagaoki, Tomokazu Kawaoka, Takashi Nakahara, Hiroshi Aikata, Daisuke Miyaki, Shoichi Takahashi, Kazuo Awai, Akira Hiramatsu, Koji Waki, Mio Tanaka, Hideaki Kakizawa, Noriaki Naeshiro, Shintaro Takaki, Yohji Honda, Masaki Ishikawa
Publikováno v:
Journal of Gastroenterology and Hepatology. 27:1850-1857
Background and Aim We compared the treatment response, survival, and safety to hepatic arterial infusion chemotherapy (HAIC) in patients with advanced hepatocellular carcinoma (HCC) according to Child–Pugh (CP) score. Methods The study subjects wer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b5ac3b86b9203291a69666f4580c4040
https://doi.org/10.1111/j.1440-1746.2012.07276.x
https://doi.org/10.1111/j.1440-1746.2012.07276.x
Autor:
Hirotaka Tashiro, Hideki Ohdan, Yoshiiku Kawakami, Hiroshi Aikata, Takashi Onoe, Hidenori Ochi, Masataka Tsuge, Nobuhiko Hiraga, Koji Waki, Akira Hiramatsu, Daiki Miki, Shintaro Takaki, Shoichi Takahashi, Kazuaki Chayama, Michio Imamura, Tomokazu Kawaoka
Publikováno v:
Journal of Gastroenterology and Hepatology. 27:1467-1472
Background and Aim: Interleukin-28B (IL28B) single nucleotide polymorphism (SNP) influences viral response (VR) to interferon (IFN) therapy in patients with hepatitis C. We studied the relationship between VR and the IL28B polymorphism (rs8099917) in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c4f57d9c4087bf0fb7eaaa190a9c0524
https://doi.org/10.1111/j.1440-1746.2012.07129.x
https://doi.org/10.1111/j.1440-1746.2012.07129.x
Autor:
Hidenori Ochi, Koji Waki, Akira Hiramatsu, Nobuhiko Hiraga, Shoichi Takahashi, Yoshiiku Kawakami, Kazuaki Chayama, Shintaro Takaki, Michio Imamura, Tomokazu Kawaoka, Hiroshi Aikata, Daiki Miki, Hirotaka Tashiro, Yoshio Katamura, Hideki Ohdan, Yuko Nagaoki, Yoshimasa Hashimoto, Masataka Tsuge
Publikováno v:
Intervirology. 55:122-126
We report a case in which sustained viral response was achieved after switching treatment from pegylated interferon (PEG-IFN) α-2b to α-2a and ribavirin (RBV) in patients with recurrence of hepatitis C virus (HCV) infection after living donor liver
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2fcbdaaf8e114fa7a653ad2aed97505e
https://doi.org/10.1159/000328661
https://doi.org/10.1159/000328661